While survival from breast and prostate cancer is increasing, there has been barely any improvement for patients with a lesser-known type of the disease – pancreatic cancer. But a new precision medicine initiative is looking to change that.
We read about new treatments for cancer nearly every single day. And that is partly because, of all the diseases, ‘cancer’ has had more new drugs approved over the last two decades than any other. Read more . . .